WORKSHOP B | 8-11AM
Time: 8:00 am
day: Pre Conference Track B
Translatable Biomarkers: Measuring Dose & Efficacy in the Clinic
- Discussing the relevance and specificity of clinical biomarkers and endpoints are currently being used for neurological trials
- Which gene therapy specific factors need to be accounted for?
- Are there novel biomarkers being trialled?